Author: Daniel B Larremore; Bailey K Fosdick; Kate M Bubar; Sam Zhang; Stephen M Kissler; C. Jessica E. Metcalf; Caroline Buckee; Yonatan Grad
Title: Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys Document date: 2020_4_20
ID: c4cs14ja_29
Snippet: There are a number of limitations to this approach that reflect uncertainties in the underlying assumptions of serological responses and the changes in mobility and interactions that have arisen in response to public health mitigation efforts, such as 'social distancing.' Serology reflects past infection, and the delay between infection and detectable immune response means that serological tests reflect a historical cumulative incidence (the date.....
Document: There are a number of limitations to this approach that reflect uncertainties in the underlying assumptions of serological responses and the changes in mobility and interactions that have arisen in response to public health mitigation efforts, such as 'social distancing.' Serology reflects past infection, and the delay between infection and detectable immune response means that serological tests reflect a historical cumulative incidence (the date of sampling minus the delay between infection and detectable response). The possibility of heterogeneous immune responses to infection and unknown dynamics and duration of immune response mean that interpretation of serological survey results may not accurately capture cumulative incidence. For COVID-19, we do not yet understand the serological correlates of protection from infection, and as such projecting seroprevalence into models that assume seropositivity indicates immunity to reinfection may be an overestimate; models would need to be updated to include partial protection or return to susceptibility.
Search related documents:
Co phrase search for related documents- cumulative incidence and detectable response: 1
- cumulative incidence and health mitigation: 1
- cumulative incidence and historical cumulative incidence: 1
- cumulative incidence and immune response: 1, 2, 3
- cumulative incidence and infection protection: 1, 2, 3
- cumulative incidence and past infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cumulative incidence and serological response: 1, 2, 3
- cumulative incidence and serological test: 1, 2, 3, 4, 5, 6, 7, 8
- cumulative incidence and social distancing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- cumulative incidence and underlie assumption: 1
Co phrase search for related documents, hyperlinks ordered by date